Mammadova et al., 2019 - Google Patents
Antibiotics and side effect of theirsMammadova et al., 2019
View PDF- Document ID
- 612995897786103045
- Author
- Mammadova K
- Hasanov H
- Baghirova S
- Rahimova R
- Dashdamirova G
- Publication year
- Publication venue
- International Journal of Medical Science and Health Research
External Links
Snippet
Antibiotics are important medicines to overcome the microbial infection, but a condition that we got a choose a proper antibiotic to destroy living of pathogen bacteria, fungus. Except all these antibiotic has damage side as to have useful, for example, to intake more much …
- 230000003115 biocidal 0 title abstract description 55
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/30—Macromolecular compounds
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin, zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113018320A (en) | Application of lactobacillus johnsonii BS15 in preparation of medicine for preventing and/or treating intestinal injury caused by chronic fluorosis | |
| HUT61478A (en) | Process for producing pharamceutical composition suitable for treating diarrhoae caused by clostridium difficile and by pseudomembranous colitis | |
| DE69934294T2 (en) | USE OF AN ANTIMICROBIAL AGENT SUCH AS TAUROLIDINE OR TAURULTAM FOR THE MANUFACTURE OF A MEDICAMENT FOR TREATING NOSOCOMIAL MICROBIAL INFECTION | |
| WO2016040785A1 (en) | Compositions and methods for treating and preventing bacterial infections | |
| Tewari et al. | Biofilm resistance to antimicrobial agents and novel approaches to combat biofilm mediated resistance in bacteria | |
| Mammadova et al. | Antibiotics and side effect of theirs | |
| KR102681178B1 (en) | Prevention and/or treatment of Pseudomonas aeruginosa infection | |
| CN1173706C (en) | Application of N-acetyl-D-glucosamine in preparation of medicine for treating cervical erosion | |
| KR20080009695A (en) | Health food and pharmaceutical composition for improving cartilage metabolic disorder | |
| Lasemi et al. | Complications of antibiotic therapy and introduction of nanoantibiotics | |
| González et al. | Antibiosis of cefotaxime/clindamycin and Lactobacillus acidophiluson related bacteria to diabetic foot ulcer | |
| RU2753606C1 (en) | Antibacterial humic agent | |
| DE60018567T2 (en) | USE OF PROPIONAIC BACTERIA FOR THE PREPARATION OF PROPIONIC ACID IN THICK DARM | |
| RU2614730C1 (en) | Antibacterial agents and method for treating intestinal yersiniosis or pseudotuberculosis, or colibacillosis | |
| Kim et al. | Update on azithromycin and cardiac side effects | |
| Chen et al. | Surface Coating of Hydroxyapatite/Antibiotics Composite Layer onto Polyetheretherketone for the Improvement of Antibacterial and Bone Cell Growth Activities | |
| KR20150117439A (en) | Pharmaceutical composition for prevention or treatment of infections caused by biofilm, and coating composition for inhibiting formation of biofilm | |
| US20240000739A1 (en) | Composition for use in treatment of a biofilm in a subject | |
| US20240366524A1 (en) | Composition and method for treating or preventing infections | |
| RU2251414C2 (en) | Preparation for treating and preventing gastro-intestinal diseases in cattle youngsters | |
| Uneze et al. | The Effect of Norbactin on the Lipid Profile of the Cardiovascular System of Albino Rats | |
| RU2246958C1 (en) | Biologically active preparation for correction of disturbance in digestive tract microflora and enhancement of general resistance of body | |
| RU2755707C1 (en) | Agent for correcting dyspeptic disorders of the gastrointestinal tract | |
| DE4236064C2 (en) | Selective toxic agent and its use | |
| RU2437663C2 (en) | Method of correcting intestinal microflora |